hepatitis B

(redirected from Chronic Hepatitis B)
Also found in: Thesaurus, Medical, Acronyms.

hepatitis B

n.
A viral hepatitis that is either acute or chronic, caused by a DNA virus, and usually transmitted by infected blood products (as through transfusion), contaminated needles, or exposure to infected bodily fluids through sexual intercourse. It can cause chronic liver damage and cancer. Also called serum hepatitis.

hepatitis B

n
(Pathology) a form of hepatitis caused by a virus transmitted by infected blood (as in transfusions), contaminated hypodermic needles, sexual contact, or by contact with any other body fluid. Former name: serum hepatitis

hepatitis B


n.
a form of hepatitis caused by a DNA virus (hepatitis B virus) that persists in the blood and has a long incubation period: usu. transmitted by sexual contact or by injection or ingestion of infected blood or other bodily fluids. Also called serum hepatitis.

hepatitis B

Inflammation of the liver caused by infection with the hepatitis B virus carried by the blood.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hepatitis B - an acute (sometimes fatal) form of viral hepatitis caused by a DNA virus that tends to persist in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids
viral hepatitis - hepatitis caused by a virus
Translations
References in periodicals archive ?
Over 95% of deaths are caused by chronic hepatitis B and C infections, while hepatitis A and E rarely cause life-threatening illnesses.
People living with chronic hepatitis B can be treated with highly effective medicines to stop the disease from progressing and reduce the risk of it developing into liver cancer.
Yet, in chronic HBV infection, HBV, HBeAg, and HBV surface antigen (HBsAg) can impair the mature and function of DCs.[10],[11],[12] However, it is not fully understood what cytokines involve in triggering the immune response against HBV during IT phase transition to immune clearance phase, and why chronic hepatitis B (CHB) patients with higher ALT level could obtain more HBeAg seroconversion after pegylated (PEG)-IFN a2 therapy.
Mehlika Toy, Ph.D., from the Stanford University School of Medicine in California, and colleagues examined the economic and public health impact of reaching the WHO targets of diagnosing and treating 90 and 80 percent of chronic hepatitis B cases, respectively, by 2030 in the United States.
About 240 million people worldwide suffer from chronic Hepatitis B. Every year an estimated 600,000 people die from it.
Chronic hepatitis B and C are highly endemic diseases, affecting people worldwide, generating an important burden.
Philadelphia, PA, September 25, 2014 --(PR.com)-- Hep B United, a national coalition co-chaired by the Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations congratulates its partners and awardees of the Centers for Disease Control and Prevention's (CDC) program, Collaborations to Improve Identification and Care for Chronic Hepatitis B Virus (HBV) Infection among Persons in the United States who were Born in Countries with Intermediate-High (>2%) HBV Prevalence.
There are many diverse causes of chronic hepatitis which can be broadly categorized into viral (Chronic hepatitis B, C and D) and non-viral causes (Alcoholic hepatitis, Non-alcoholic steatohepatitis, Wilson's disease, Drugs, Auto-immune hepatitis and others) (1-3).
Chronic hepatitis B remains the most common serious health problem in the world, especially in the Asia Pacific region.
In the United States, an estimated 3.5-5.3 million persons have chronic hepatitis B or chronic hepatitis C, and as many as three fourths of those with hepatitis C are unaware they are infected.
Full browser ?